Equity Analysis

Company News

    Remus Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    78788
    INE0O5T01011
    139.278683
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    REMUS
    82.72
    1390.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    28.52
    10
    0
     
Remus Pharmaceuticals Ltd
Remus Pharmaceuticals Ltd - Remus Pharmaceuticals Limited - Board Meeting
Nov 06,2024
Remus Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Dividend/Other business.